MorphoSys Historical Income Statement

MOR Stock  USD 17.62  0.11  0.63%   
Historical analysis of MorphoSys income statement accounts such as Total Revenue of 250.2 M can show how well MorphoSys AG ADR performed in making a profits. Evaluating MorphoSys income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of MorphoSys's future profits or losses.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining MorphoSys AG ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MorphoSys AG ADR is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MorphoSys AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

About MorphoSys Income Statement Analysis

MorphoSys AG ADR Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to MorphoSys shareholders. The income statement also shows MorphoSys investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

MorphoSys Income Statement Chart

MorphoSys AG ADR Income Statement is one of the three primary financial statements used for reporting MorphoSys's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of MorphoSys AG ADR revenue and expense. MorphoSys Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, MorphoSys' Cost Of Revenue is relatively stable compared to the past year.

Total Revenue

Total revenue comprises all receipts MorphoSys AG ADR generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of MorphoSys AG ADR minus its cost of goods sold. It is profit before MorphoSys operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of MorphoSys AG ADR. It is also known as MorphoSys overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from MorphoSys' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into MorphoSys AG ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MorphoSys AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
At this time, MorphoSys' Cost Of Revenue is relatively stable compared to the past year.
 2021 2022 2023 2024 (projected)
Interest Expense181.5M116.5M109.9M115.4M
Depreciation And Amortization98.4M10.5M10.5M10.4M

MorphoSys income statement Correlations

0.690.450.240.210.46-0.51-0.640.36-0.470.48-0.91-0.88-0.86-0.370.3-0.87-0.37-0.26-0.060.50.74
0.690.920.820.680.93-0.39-0.270.86-0.120.94-0.69-0.73-0.73-0.060.81-0.73-0.050.240.360.940.63
0.450.920.830.610.98-0.42-0.20.94-0.110.98-0.55-0.48-0.650.140.95-0.650.150.410.30.960.36
0.240.820.830.910.86-0.010.210.80.310.87-0.2-0.42-0.260.080.75-0.260.080.430.690.860.47
0.210.680.610.910.650.240.370.570.490.67-0.07-0.49-0.080.030.46-0.090.030.380.780.730.59
0.460.930.980.860.65-0.4-0.190.98-0.11.0-0.55-0.5-0.660.150.94-0.660.160.420.310.960.38
-0.51-0.39-0.42-0.010.24-0.40.93-0.40.93-0.390.80.10.720.44-0.470.710.440.450.24-0.31-0.14
-0.64-0.27-0.20.210.37-0.190.93-0.170.98-0.190.860.250.740.54-0.20.740.530.60.36-0.13-0.26
0.360.860.940.80.570.98-0.4-0.17-0.10.98-0.49-0.4-0.630.260.95-0.630.270.50.210.90.22
-0.47-0.12-0.110.310.49-0.10.930.98-0.1-0.090.740.050.620.52-0.140.620.510.620.39-0.02-0.1
0.480.940.980.870.671.0-0.39-0.190.98-0.09-0.56-0.53-0.660.130.93-0.660.140.410.340.960.41
-0.91-0.69-0.55-0.2-0.07-0.550.80.86-0.490.74-0.560.670.940.42-0.460.940.410.330.12-0.54-0.58
-0.88-0.73-0.48-0.42-0.49-0.50.10.25-0.40.05-0.530.670.690.11-0.270.690.11-0.07-0.14-0.59-0.8
-0.86-0.73-0.65-0.26-0.08-0.660.720.74-0.630.62-0.660.940.690.09-0.61.00.080.020.27-0.63-0.42
-0.37-0.060.140.080.030.150.440.540.260.520.130.420.110.090.270.091.00.92-0.370.12-0.59
0.30.810.950.750.460.94-0.47-0.20.95-0.140.93-0.46-0.27-0.60.27-0.60.270.470.140.880.1
-0.87-0.73-0.65-0.26-0.09-0.660.710.74-0.630.62-0.660.940.691.00.09-0.60.080.020.27-0.63-0.42
-0.37-0.050.150.080.030.160.440.530.270.510.140.410.110.081.00.270.080.93-0.360.13-0.59
-0.260.240.410.430.380.420.450.60.50.620.410.33-0.070.020.920.470.020.93-0.020.42-0.32
-0.060.360.30.690.780.310.240.360.210.390.340.12-0.140.27-0.370.140.27-0.36-0.020.380.58
0.50.940.960.860.730.96-0.31-0.130.9-0.020.96-0.54-0.59-0.630.120.88-0.630.130.420.380.49
0.740.630.360.470.590.38-0.14-0.260.22-0.10.41-0.58-0.8-0.42-0.590.1-0.42-0.59-0.320.580.49
Click cells to compare fundamentals

MorphoSys Account Relationship Matchups

MorphoSys income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization6.2M8.3M98.4M10.5M10.5M10.4M
Interest Expense2.3M96.2M181.5M116.5M109.9M115.4M
Selling General Administrative36.7M51.4M78.3M83.9M86.2M90.5M
Total Revenue71.8M327.7M179.6M278.3M238.3M250.2M
Gross Profit59.7M318.5M147.4M229.6M179.9M96.7M
Other Operating Expenses179.9M309.7M457.2M499.0M489.1M513.6M
Operating Income(105.1M)119.4M(277.6M)162.3M(252.5M)(239.9M)
Ebit(105.1M)119.4M(277.6M)162.3M(108.3M)(102.9M)
Research Development108.4M141.4M225.2M297.8M283.6M297.8M
Ebitda(98.9M)127.7M(179.2M)172.8M(97.7M)(92.9M)
Total Operating Expenses167.8M300.6M425M450.4M430.8M452.3M
Income Before Tax(106.5M)22.5M(591.1M)17.5M(190.9M)(181.4M)
Total Other Income Expense Net(1.4M)(96.9M)(313.5M)(144.7M)20.0M21.0M
Net Income(103.0M)97.9M(514.5M)(151.1M)(189.7M)(180.2M)
Income Tax Expense(3.5M)(75.4M)(76.6M)168.6M(1.2M)(1.1M)
Cost Of Revenue12.1M9.2M32.2M48.6M58.4M61.3M
Net Income From Continuing Ops(103.0M)97.9M(514.5M)(151.1M)(189.7M)(180.2M)
Net Income Applicable To Common Shares(103.0M)97.9M(514.5M)(151.1M)(136.0M)(142.7M)
Tax Provision(3.5M)(75.4M)(76.6M)168.6M(1.2M)(1.1M)
Net Interest Income527.1K(4.2M)(68.3M)270.8M39.9M32.9M
Interest Income2.8M92.0M723K4.6M18.3M16.5M
Reconciled Depreciation6.2M8.3M10.1M10.5M10.5M8.4M
Selling And Marketing Expenses22.7M107.7M121.5M6.3M6.3M6.0M

MorphoSys Investors Sentiment

The influence of MorphoSys' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in MorphoSys. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to MorphoSys' public news can be used to forecast risks associated with an investment in MorphoSys. The trend in average sentiment can be used to explain how an investor holding MorphoSys can time the market purely based on public headlines and social activities around MorphoSys AG ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MorphoSys' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MorphoSys' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average MorphoSys' news discussions. The higher the estimated score, the more favorable is the investor's outlook on MorphoSys.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MorphoSys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MorphoSys' short interest history, or implied volatility extrapolated from MorphoSys options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MorphoSys AG ADR is a strong investment it is important to analyze MorphoSys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MorphoSys' future performance. For an informed investment choice regarding MorphoSys Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MorphoSys AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for MorphoSys Stock analysis

When running MorphoSys' price analysis, check to measure MorphoSys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MorphoSys is operating at the current time. Most of MorphoSys' value examination focuses on studying past and present price action to predict the probability of MorphoSys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MorphoSys' price. Additionally, you may evaluate how the addition of MorphoSys to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is MorphoSys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MorphoSys. If investors know MorphoSys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MorphoSys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
(1.48)
Revenue Per Share
1.736
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.07)
The market value of MorphoSys AG ADR is measured differently than its book value, which is the value of MorphoSys that is recorded on the company's balance sheet. Investors also form their own opinion of MorphoSys' value that differs from its market value or its book value, called intrinsic value, which is MorphoSys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MorphoSys' market value can be influenced by many factors that don't directly affect MorphoSys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MorphoSys' value and its price as these two are different measures arrived at by different means. Investors typically determine if MorphoSys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MorphoSys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.